Trial Profile
A Pilot Study of Photodynamic Therapy (PDT) Using Aminolaevulinic Acid (ALA) in Patients With HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Jul 2019
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Cervical intraepithelial neoplasia
- Focus Therapeutic Use
- Sponsors Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
- 05 Jul 2019 Status changed from recruiting to completed.
- 13 Feb 2019 Planned End Date changed from 1 Nov 2018 to 1 Nov 2019.
- 13 Feb 2019 Planned primary completion date changed from 1 Aug 2018 to 1 Aug 2019.